Nahum Amit, Garty Ben Zion, Marcus Nufar, Shoenfeld Tommy, Levy Yael
Department of Pediatrics, Kaplan Medical Center, Rehovot, Hebrew University, Hadassah Medical School Jerusalem, Israel.
Pediatr Emerg Care. 2009 May;25(5):339-41. doi: 10.1097/PEC.0b013e3181a34901.
To present 3 children with hypersensitivity reaction to methylprednisolone sodium-succinate and review the literature regarding such reactions.
Data on the clinical features were obtained from the children's files. Skin prick tests were performed with a panel of corticosteroid preparations.
Three patients (5, 7, and 8 years) with asthma who were treated with intravenous methylprednisolone succinate at the emergency department developed hypersensitivity reactions initially consider to be due to their primary disease. Two had a positive skin prick test to methylprednisolone sodium succinate but not to other corticosteroids or to the succinate ester. Skin prick tests to different corticosteroids, performed 4 years after the event in the third patient, were negative.
Methylprednisolone sodium-succinate may cause anaphylactic/anaphylactoid reactions in children. Our patients' histories emphasize the importance of awareness to corticosteroid-induced reactions, especially in children with asthma in whom the symptoms may be considered as an exacerbation of their primary illness.
介绍3例对甲泼尼龙琥珀酸钠过敏的儿童病例,并回顾有关此类反应的文献。
从儿童病历中获取临床特征数据。用一组皮质类固醇制剂进行皮肤点刺试验。
3例(年龄分别为5岁、7岁和8岁)哮喘患儿在急诊科接受静脉注射甲泼尼龙琥珀酸钠治疗时出现过敏反应,最初被认为是由其原发性疾病所致。其中2例对甲泼尼龙琥珀酸钠皮肤点刺试验呈阳性,但对其他皮质类固醇或琥珀酸酯呈阴性。事件发生4年后对第3例患者进行的不同皮质类固醇皮肤点刺试验结果为阴性。
甲泼尼龙琥珀酸钠可能会在儿童中引起过敏/类过敏反应。我们患者的病史强调了认识皮质类固醇诱发反应的重要性,尤其是在哮喘儿童中,其症状可能被视为原发性疾病的加重。